Amgen Inc.

Amgen Inc.verified

AMGN

Price:

$347.715

Market Cap:

$187.66B

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infectio...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1983-06-17

Stock Exchange

NASDAQ

Ticker

AMGN

The Enterprise Value as of June 2026 (TTM) for Amgen Inc. (AMGN) is 232.95B

According to Amgen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 232.95B. This represents a change of 9.30% compared to the average of 213.13B of the last 4 quarters.

Amgen Inc. (AMGN) Historical Enterprise Value (quarterly & annually)

How has AMGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Amgen Inc. over the last ten years is 173.08B. The current 232.95B Enterprise Value has changed 13.36% with respect to the historical average. Over the past ten years (40 quarters), AMGN's Enterprise Value was at its highest in in the March 2026 quarter at 235.28B. The Enterprise Value was at its lowest in in the September 2019 quarter at 134.29B.

Quarterly (TTM)
Annual

Average

173.08B

Median

165.58B

Minimum

140.72B

Maximum

221.57B

Amgen Inc. (AMGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amgen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 20.36%

Maximum Annual Enterprise Value = 221.57B

Minimum Annual Increase = -8.97%

Minimum Annual Enterprise Value = 140.72B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025221.57B17.15%
2024189.13B-8.97%
2023207.76B20.36%
2022172.62B12.41%
2021153.55B-4.89%
2020161.45B-4.87%
2019169.71B9.03%
2018155.66B-1.89%
2017158.66B12.75%
2016140.72B-6.39%

Amgen Inc. (AMGN) Average Enterprise Value

How has AMGN Enterprise Value performed in the past?

The current Enterprise Value of Amgen Inc. (AMGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

206.15B

5-year avg

188.93B

10-year avg

173.08B

Amgen Inc. (AMGN) Enterprise Value vs. Peers

How is AMGN’s Enterprise Value compared to its peers?

Amgen Inc.’s Enterprise Value is greater than Gilead Sciences, Inc. (172.49B), greater than Pfizer Inc. (211.88B), greater than Sanofi (104.77B), less than Merck & Co., Inc. (329.05B), greater than Danaher Corporation (141.13B), greater than Bristol-Myers Squibb Company (149.32B), less than Novo Nordisk A/S (1.39T), greater than Boston Scientific Corporation (78.38B), greater than GSK plc (94.65B), less than Novartis AG (331.13B),

CompanyEnterprise ValueMarket cap
172.49B$157.94B
211.88B$149.13B
104.77B$104.43B
329.05B$285.26B
141.13B$128.35B
149.32B$114.44B
1.39T$197.30B
78.38B$68.87B
94.65B$105.73B
331.13B$290.70B

Build a custom stock screener for Amgen Inc. (AMGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amgen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amgen Inc. (AMGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amgen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amgen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Amgen Inc. (AMGN)?

What is the 3-year average Enterprise Value for Amgen Inc. (AMGN)?

What is the 5-year average Enterprise Value for Amgen Inc. (AMGN)?

How does the current Enterprise Value for Amgen Inc. (AMGN) compare to its historical average?